Weichert W, Breddin H K
Department of Internal Medicine, J.W. Goethe University, Frankfurt/Main, FRG.
Haemostasis. 1989;19(4):229-34. doi: 10.1159/000215922.
N 48740 RP, a pyrrolo(1,2-c)thiazole derivative and platelet-activating factor inhibitor, was tested in a thrombosis model, in which thrombi are produced in small rat mesenteric vessels. A phase contrast system, based on a Leitz Orthoplan microscope, was used to visualize thrombus formation. Vascular lesions were produced with a Coherent CR-2 supergraphite ion laser (argon laser) in vessels of 25-35 microns diameter. The results show a dose-dependent (5-20 mg/kg i.v.) antithrombotic effect of N 48740 RP which reaches its maximum between 30 min and 2 h after the injection and slowly decreases during the following 24-48 h.
N 48740 RP是一种吡咯并(1,2 - c)噻唑衍生物和血小板激活因子抑制剂,在一种血栓形成模型中进行了测试,该模型中血栓在大鼠小肠系膜小血管中形成。基于Leitz Orthoplan显微镜的相差系统用于观察血栓形成。使用相干CR - 2超石墨离子激光(氩激光)在直径为25 - 35微米的血管中造成血管损伤。结果显示,N 48740 RP具有剂量依赖性(静脉注射5 - 20毫克/千克)的抗血栓作用,在注射后30分钟至2小时达到最大值,并在随后的24 - 48小时内缓慢下降。